Literature DB >> 16439015

Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain.

Shu Lin1, Dana Boey, Nicola Lee, Christoph Schwarzer, Amanda Sainsbury, Herbert Herzog.   

Abstract

Using radioactive in situ hybridisation, the distribution of prodynorphin mRNA in the brains of C57Bl/6 mice was systemically investigated, and double-labelling in situ hybridisation was used to determine the extent to which neuropeptide Y (NPY) and prodynorphin mRNAs were co-expressed. Our results demonstrate that prodynorphin mRNA expression in the mouse brain is localised at specific subregions of the olfactory bulb, cortex, hippocampus, amygdala, basal ganglia, thalamus, hypothalamus, mesencephalon and myelencephalon. Among the regions displaying the most intense labelling were the olfactory tubercle, lateral septum (LS), caudate putamen (Cpu), central amygdaloid nucleus (Ce), paraventricular hypothalamic nucleus (PVN), supraoptic nucleus (SO), lateral hypothalamic area (LHA), ventromedial hypothalamic nucleus (VMH), lateral reticular nucleus (LRt) and solitary tract nucleus (NTS). In the arcuate nucleus of the hypothalamus (Arc), double-labelling in situ hybridisation revealed that prodynorphin expressing neurons also contained NPY mRNA, with a co-localisation rate of approximately 88% in the lateral part of the Arc, and 79% in the dorsal part of the Arc, respectively, suggesting potential overlapping functions of these two neurotransmitters in feeding type behaviour.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439015     DOI: 10.1016/j.npep.2005.11.006

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  24 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

Review 3.  Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

Authors:  Rachel I Anderson; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-06-05       Impact factor: 3.455

4.  Oxytocin Intranasal Administration Affects Neural Networks Upstream of GNRH Neurons.

Authors:  Mohammad Saied Salehi; Homayoun Khazali; Fariba Mahmoudi; Mahyar Janahmadi
Journal:  J Mol Neurosci       Date:  2017-06-29       Impact factor: 3.444

5.  Characterization of BU09059: a novel potent selective κ-receptor antagonist.

Authors:  Joseph J Casal-Dominguez; Daniel Furkert; Mehrnoosh Ostovar; Linnea Teintang; Mary J Clark; John R Traynor; Stephen M Husbands; Sarah J Bailey
Journal:  ACS Chem Neurosci       Date:  2014-01-28       Impact factor: 4.418

Review 6.  Hypothalamic neuropeptide signaling in alcohol addiction.

Authors:  Jessica R Barson; Sarah F Leibowitz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-14       Impact factor: 5.067

Review 7.  Role of kappa-opioid receptors in stress and anxiety-related behavior.

Authors:  Ashlee Van't Veer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

8.  Activation of κ opioid receptors increases intrinsic excitability of dentate gyrus granule cells.

Authors:  Carmel M McDermott; Laura A Schrader
Journal:  J Physiol       Date:  2011-05-23       Impact factor: 5.182

Review 9.  Dynorphin, stress, and depression.

Authors:  Allison T Knoll; William A Carlezon
Journal:  Brain Res       Date:  2009-09-24       Impact factor: 3.252

Review 10.  High-resolution gene expression atlases for adult and developing mouse brain and spinal cord.

Authors:  Alex M Henry; John G Hohmann
Journal:  Mamm Genome       Date:  2012-07-26       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.